The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Nurix Therapeutics Inc’s stock clocked out at $21.18, up 1.78% from its previous closing price of $20.81. In other words, the price has increased by $1.78 from its previous closing price. On the day, 0.68 million shares were traded. NRIX stock price reached its highest trading level at $21.31 during the session, while it also had its lowest trading level at $20.41.
Ratios:
To gain a deeper understanding of NRIX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.28 and its Current Ratio is at 5.28. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 10, 2024, initiated with a Buy rating and assigned the stock a target price of $35.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $35.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $35.UBS initiated its Buy rating on October 24, 2024, with a $35 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 02 ’24 when Ring Christine sold 5,760 shares for $21.73 per share. The transaction valued at 125,155 led to the insider holds 28,084 shares of the business.
CHRISTINE RING bought 5,760 shares of NRIX for $127,354 on Dec 02 ’24. On Nov 04 ’24, another insider, Ring Christine, who serves as the Chief Legal Officer of the company, sold 3,290 shares for $25.00 each. As a result, the insider received 82,250 and left with 28,084 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRIX now has a Market Capitalization of 1500312960 and an Enterprise Value of 1079403392. For the stock, the TTM Price-to-Sale (P/S) ratio is 26.59 while its Price-to-Book (P/B) ratio in mrq is 3.77. Its current Enterprise Value per Revenue stands at 19.13 whereas that against EBITDA is -5.791.
Stock Price History:
Over the past 52 weeks, NRIX has reached a high of $29.56, while it has fallen to a 52-week low of $7.65. The 50-Day Moving Average of the stock is -10.36%, while the 200-Day Moving Average is calculated to be 6.67%.
Shares Statistics:
It appears that NRIX traded 907.64K shares on average per day over the past three months and 912670 shares per day over the past ten days. A total of 70.84M shares are outstanding, with a floating share count of 68.89M. Insiders hold about 2.74% of the company’s shares, while institutions hold 95.14% stake in the company. Shares short for NRIX as of 1732838400 were 9346993 with a Short Ratio of 10.30, compared to 1730332800 on 9457834. Therefore, it implies a Short% of Shares Outstanding of 9346993 and a Short% of Float of 14.16.
